| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Viracta Therapeutics, Inc. (VIRX) has 0 insiders with recent SEC Form 4 filings, including 7 buys and 14 sells. VIRX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 25, 2016 | Parker Geoffrey M.47 | Director | Buy | 52,505 | $0.47 | $24,813.93 | +175.0% | |
| Dec 21, 2015 | Misfeldt Dayton | Director | Buy | 1,750,000 | $0.84 | $1,470,000.00 | +31.1% | |
| Aug 25, 2015 | Swisher Daniel N Jr49 | President And CEO | Buy | 25,000 | $1.01 | $25,250.00 | +6.9% | |
| Jul 24, 2015 | Misfeldt Dayton | Director | Sell | 635,702 | $3.46 | $2,200,242.08 | -5.5% | |
| Jul 24, 2015 | Ketchum Steven B | Director | Sell | 6,358 | $3.46 | $21,989.14 | -3.7% | |
| Jul 24, 2015 | Bay City Capital LLC | 10% Owner | Sell | 635,702 | $3.46 | $2,199,528.92 | -2.8% | |
| Jul 24, 2015 | Bjerkholt Eric70 | EVP, CFO &Corp. Secretary | Sell | 6,358 | $3.46 | $21,989.14 | -3.7% | |
| Jul 24, 2015 | Swisher Daniel N Jr49 | President And CEO | Sell | 12,715 | $3.46 | $43,974.83 | -4.2% | |
| Jul 24, 2015 | Swisher Daniel N Jr49 | President And CEO | Buy | 25,000 | $1.02 | $25,457.50 | +16.7% |